Show simple item record

dc.contributor.authorPatel, Karanen
dc.contributor.authorRack, Samuelen
dc.contributor.authorMistry, H.en
dc.contributor.authorHeathcote, Emilyen
dc.contributor.authorBetts, G.en
dc.contributor.authorHarrington, K. J.en
dc.contributor.authorMetcalf, Roberten
dc.date.accessioned2023-10-25T08:48:38Z
dc.date.available2023-10-25T08:48:38Z
dc.date.issued2023en
dc.identifier.citationPatel K, Rack S, Mistry H, Heathcote E, Betts G, Harrington KJ, et al. Tumour mutational burden as a predictive and prognostic biomarker in locally advanced and recurrent/metastatic adenoid cystic carcinoma. Journal of Clinical Oncology. 2023 Jun;41(16). PubMed PMID: WOS:001053772004086.en
dc.identifier.doi10.1200/JCO.2023.41.16_suppl.e18086en
dc.identifier.urihttp://hdl.handle.net/10541/626659
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1200/JCO.2023.41.16_suppl.e18086en
dc.titleTumour mutational burden as a predictive and prognostic biomarker in locally advanced and recurrent/metastatic adenoid cystic carcinomaen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentThe Christie Hospital NHS Foundation Trust, Manchesteren
dc.identifier.journalJournal of Clinical Oncologyen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record